United States: Drug Pricing Déjà Vu: The Biden-Harris Administration's Fiscal Year 2024 Budget Doubles Down On Inflation Reduction Act Reforms; CMMI And MedPAC Also Weigh In - Akin Gump Strauss Hauer & Feld LLP
As outlined in our prior analysis, the Inflation Reduction Act (IRA) included sweeping drug pricing reforms for the Medicare program and the Biden-Harris administration has made clear...
Full Article